BENZENO SHARON
Chief Commercial Ofc Imm Med
BENZENO SHARON has filed 5 SEC Form 4 filings (23 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$14.7M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| ADPT | Chief Commercial Ofc Imm Med | Sale | 11,034 | $232K | Jun 30 | SEC ↗ | |
| ADPT | Chief Commercial Ofc Imm Med | Sale | 154,768 | $3.3M | Jun 30 | SEC ↗ | |
| ADPT | Chief Commercial Ofc Imm Med | Sale | 63,103 | $831K | Mar 13 | SEC ↗ | |
| ADPT | Chief Commercial Ofc Imm Med | Sale | 12,604 | $212K | Dec 8 | SEC ↗ | |
| ADPT | Chief Commercial Ofc Imm Med | Sale | 297,925 | $4.9M | Nov 24 | SEC ↗ | |
| ADPT | Chief Commercial Ofc Imm Med | Sale | 308,477 | $5.2M | Nov 24 | SEC ↗ |